Regulation of the European Parliament and of the Council on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease = Adoption of the legislative act = Derogation from the 8-week period provided for in Article 4 of Protocol 1 on the role of national Parliaments in the EU = Outcome of the written procedure completed on 14 July 2020